Description
An unprecedented constellation of experts--leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more--explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future.
The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today's leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success.
Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer's many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients.
Author: Abbe R. Gluck
Publisher: PublicAffairs
Published: 11/16/2021
Pages: 416
Binding Type: Hardcover
Weight: 1.40lbs
Size: 9.20h x 6.40w x 1.40d
ISBN13: 9781541700611
ISBN10: 1541700619
BISAC Categories:
- Medical | Health Policy
- Medical | Health Care Delivery
About the Author
Abbe R. Gluck is a Professor of Law and the founding Faculty Director of the Solomon Center for Health Law and Policy at Yale Law School. She is also Professor of Internal Medicine (General Medicine) at Yale Medical School and a Professor in the Institution for Social and Policy Studies at Yale. Charles Fuchs became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously professor of medicine at Harvard Medical School and chief of the gastrointestinal oncology division and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.